ArriVent BioPharma Stock Forecast - Accumulation Distribution
| AVBP Stock | 23.22 0.00 0.00% |
ArriVent Stock outlook is based on your current time horizon. Although ArriVent BioPharma's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of ArriVent BioPharma's systematic risk associated with finding meaningful patterns of ArriVent BioPharma fundamentals over time.
As of today, The RSI of ArriVent BioPharma's share price is at 55. This suggests that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling ArriVent BioPharma, making its price go up or down. Momentum 55
Impartial
Oversold | Overbought |
EPS Estimate Next Quarter (0.79) | EPS Estimate Current Year (4.29) | EPS Estimate Next Year (3.91) | Wall Street Target Price 40.2333 | EPS Estimate Current Quarter (0.78) |
Using ArriVent BioPharma hype-based prediction, you can estimate the value of ArriVent BioPharma Common from the perspective of ArriVent BioPharma response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards ArriVent BioPharma using ArriVent BioPharma's stock options and short interest. It helps to benchmark the overall future attitude of investors towards ArriVent using crowd psychology based on the activity and movement of ArriVent BioPharma's stock price.
ArriVent BioPharma Implied Volatility | 2.65 |
ArriVent BioPharma's implied volatility exposes the market's sentiment of ArriVent BioPharma Common stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if ArriVent BioPharma's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that ArriVent BioPharma stock will not fluctuate a lot when ArriVent BioPharma's options are near their expiration.
ArriVent BioPharma after-hype prediction price | USD 23.22 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of ArriVent BioPharma to cross-verify your projections. Prediction based on Rule 16 of the current ArriVent contract
Based on the Rule 16, the options market is currently suggesting that ArriVent BioPharma Common will have an average daily up or down price movement of about 0.17% per day over the life of the 2026-04-17 option contract. With ArriVent BioPharma trading at USD 23.22, that is roughly USD 0.0385 . If you think that the market is fully incorporating ArriVent BioPharma's daily price movement you should consider acquiring ArriVent BioPharma Common options at the current volatility level of 2.65%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-04-17 ArriVent Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast ArriVent BioPharma's spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in ArriVent BioPharma's options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for ArriVent BioPharma stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current ArriVent BioPharma's open interest, investors have to compare it to ArriVent BioPharma's spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of ArriVent BioPharma is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in ArriVent. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
ArriVent BioPharma Additional Predictive Modules
Most predictive techniques to examine ArriVent price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for ArriVent using various technical indicators. When you analyze ArriVent charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Check ArriVent BioPharma Volatility | Backtest ArriVent BioPharma | Information Ratio |
ArriVent BioPharma Trading Date Momentum
| On January 26 2026 ArriVent BioPharma Common was traded for 23.21 at the closing time. The top price for the day was 25.80 and the lowest listed price was 23.04 . There was no trading activity during the period 0.0. Lack of trading volume on January 26, 2026 did not affect price variability. The overall trading delta against the current closing price is 0.00% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare ArriVent BioPharma to competition |
Other Forecasting Options for ArriVent BioPharma
For every potential investor in ArriVent, whether a beginner or expert, ArriVent BioPharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. ArriVent Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in ArriVent. Basic forecasting techniques help filter out the noise by identifying ArriVent BioPharma's price trends.ArriVent BioPharma Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ArriVent BioPharma stock to make a market-neutral strategy. Peer analysis of ArriVent BioPharma could also be used in its relative valuation, which is a method of valuing ArriVent BioPharma by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
ArriVent BioPharma Market Strength Events
Market strength indicators help investors to evaluate how ArriVent BioPharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading ArriVent BioPharma shares will generate the highest return on investment. By undertsting and applying ArriVent BioPharma stock market strength indicators, traders can identify ArriVent BioPharma Common entry and exit signals to maximize returns.
| Accumulation Distribution | 0.11 | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 24.42 | |||
| Day Typical Price | 24.02 | |||
| Market Facilitation Index | 2.76 | |||
| Price Action Indicator | (1.20) | |||
| Relative Strength Index | 55.53 |
ArriVent BioPharma Risk Indicators
The analysis of ArriVent BioPharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in ArriVent BioPharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting arrivent stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.18 | |||
| Semi Deviation | 3.34 | |||
| Standard Deviation | 4.03 | |||
| Variance | 16.22 | |||
| Downside Variance | 12.5 | |||
| Semi Variance | 11.14 | |||
| Expected Short fall | (3.80) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for ArriVent BioPharma
The number of cover stories for ArriVent BioPharma depends on current market conditions and ArriVent BioPharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that ArriVent BioPharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about ArriVent BioPharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
ArriVent BioPharma Short Properties
ArriVent BioPharma's future price predictability will typically decrease when ArriVent BioPharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of ArriVent BioPharma Common often depends not only on the future outlook of the potential ArriVent BioPharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. ArriVent BioPharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 31.5 M | |
| Cash And Short Term Investments | 218.9 M |
Additional Tools for ArriVent Stock Analysis
When running ArriVent BioPharma's price analysis, check to measure ArriVent BioPharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ArriVent BioPharma is operating at the current time. Most of ArriVent BioPharma's value examination focuses on studying past and present price action to predict the probability of ArriVent BioPharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ArriVent BioPharma's price. Additionally, you may evaluate how the addition of ArriVent BioPharma to your portfolios can decrease your overall portfolio volatility.